Navigation Links
Malaria Vaccine May Be 10 Years Away

Scientists in past centuries called the sickness by the Italian phrase 'malaria' — or 'bad air' — for the supposedly disease-bearing zephyrs wafting from swamps.

These days, scientists know malaria is spread by mosquitos. // And they say ill winds are buffeting their attempts to halt the spread of a disease that kills 1 million people a year, AP reports.

'We need to stress that the situation is bad. The number of deaths are rising, infections are rising,' said Pierre Druilhe, head of the biomedical unit at France's Pasteur Institute.

Scientists say it could take more than 10 years before a fully effective malaria vaccine is approved for use.

Hundreds of malaria experts gathered this week in Yaounde, Cameroon, for a conference on the disease. And while many scientists described solid recent advancements and reason for cautious optimism, others said the news isn't good for Africa.

While malaria has been all but eradicated in wealthy nations, scientists say they're hindered in Africa by twin hurdles: insecticide resistance in mosquitoes and drug resistance in the parasite.

Malaria is spread by mosquitoes and causes wracking pain, fever and, if left untreated, death. It kills more African children than any other disease, and is the leading cause of death of those under 5 in sub-Saharan Africa.

African poverty means few buyers for even relatively inexpensive insecticide-treated bed nets, so many companies shy away from producing them, scientists say. And anti-malarial drugs can be costly.

Malaria prevention is 'in trouble,' Brian Greenwood of the London School of Hygiene and Tropical Medicine said by telephone from Cameroon.

For Greenwood, the main problem is increased resistance to drugs, particularly the longtime mainstay, chloroquine, which is relatively cheap to produce in mass quantities.

Medical workers are turning to a new drug called artemisinin, derived fr om an herb indigenous to Asia. Drawing on lessons learned from treating HIV and AIDS, doctors are using artemisinin with other drugs. But production is slow and expensive.

'It's a plant that takes 18 months to grow. You can't just say that you need 20 million doses right now,' Greenwood said.

Without chloroquine and the insecticide DDT — which helped eradicate malaria in the United States and Europe but was ultimately believed by many to cause cancer and harm the environment — anti-malaria campaigners say they've lost two key weapons.

'It's pretty straightforward,' Druilhe said by telephone from Cameroon. 'We have today far less means to control malaria than 50 years ago.'

This means, he said, that 'the next decade will be a very bad decade.'

As for new insecticides, scientists say there are only pockets of resistance in the mosquitoes that carry malaria — at least so far.

'If you had in one place a high level of resistance to both drugs and insecticides, it would be a disaster,' Greenwood said.

Malaria, with over a half billion infections worldwide, is a major contributor to African poverty, scientists say, cutting billions from gross domestic product while weighing on health care systems.

But not all is calamity. Scientists say they've identified a resurgence in public and political interest in malaria over the past decade, a change they ascribe to greater media coverage and increased tourism in countries where the disease is a threat.

Malaria, Greenwood said, 'has dropped into the mainstream.'

Plus, scientists are increasingly banding together to study the problem — as they did this week in Cameroon — while philanthropists like Microsoft founder Bill Gates have donated huge amounts of money to fight the disease.

But Druilhe said more cash is needed. 'There's a need for the developing countries to put some pressure on the rich countries of t he north,' h said.
'"/>




Related medicine news :

1. Malaria strikes Munger tribals
2. Sponging Cattle betters spraying in eradicating Malaria
3. Gene researchers make Malaria-resistant mosquito
4. More Treatment Options For Malaria
5. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
6. Jharkhand reports 13,000 Malaria cases
7. Researchers Discover Protein That Causes Malaria
8. Malarial gene ascertained
9. Artesunate Is Better For Malaria Than Quinine
10. New Strategies For Effective Treatment Of Malaria
11. Chloroquine and Primaquine combination Malarial drug for resistant parasites.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... ... February 23, 2017 , ... Healthcare Research & Analytics® ... the fight against cancer, has produced a seminal study that asked cancer survivors ... top-line findings in a webinar, Defining Compassionate Care Through the Voices of Patients ...
(Date:2/23/2017)... ... (PRWEB) February ... for the nation to come together to combine its favorite ... with its favorite fruit – apples! To celebrate National Nutrition ... join the “Apple Madness” bracket tournament – a five-week, five-round ...
(Date:2/23/2017)... ... 23, 2017 , ... Top cosmetic and periodontal dentist Dr. Mahnaz Rashti ... new Indiegogo campaign . Individuals are now able to contribute to the local ... either as a participating patient or through an Indiegogo donation. The entirety of proceeds ...
(Date:2/23/2017)... ... 23, 2017 , ... HealthPostures, the desk for standing designer headquartered in Prior ... to the Minneapolis Home and Garden Show which is being held February 24 through ... attention is the Minneapolis Convention Center. , From its broad line of sit ...
(Date:2/23/2017)... ... February 23, 2017 , ... Carlos Gutierrez has ... also continued to spiritually evolve, which is the purpose of everyone in this universe. ... Truths ” (published by Balboa Press) attempts to guide readers to expand one’s spiritual ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... MIAMI , February 23, 2017 ML ... stake in Colorado Highlife Tours , a ... strategic plan in partnership with Puration, Inc. (USOTC: PURA) to enter ... luxury cannabis tours product. The Colorado Highlife Tours acquisition announced today ... cannabis tourism strategy. ...
(Date:2/23/2017)... , Feb. 23, 2017 Provectus Biopharmaceuticals, Inc. ... a clinical-stage oncology and dermatology biopharmaceutical company, today announced ... Dominic Rodrigues as special advisers to the ... will advise the board on financial and corporate strategy. ... an investment commitment of up to $2.5 million from ...
(Date:2/23/2017)... NEW YORK , Feb. 22, 2017 /PRNewswire/ ... to the non-hodgkin lymphoma partnering deals and agreements ... Read the full report: http://www.reportlinker.com/p03605669-summary/view-report.html ... and Agreements since 2010 report provides understanding and ... by the world,s leading healthcare companies. ...
Breaking Medicine Technology: